{"id":"W3013759133","doi":"10.1016/s2665-9913(20)30036-9","title":"Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Novartis Pharma; National Institute for Health and Care Research","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Psoriasis Area and Severity Index; Placebo; Internal medicine; Rheumatology; Psoriasis; Clinical trial; Adverse effect; Dermatology; Arthritis; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005752692,0.001562606,0.003000841,0.0003356748,0.0006068644,0.00143377,0.0007317669,0.001853934,0.001582444],"category_scores_gemma":[0.002492079,0.0004702025,0.004381078,0.0003618182,0.0008499168,0.001473728,0.0005616749,0.002758248,0.0004590284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007092665,"about_ca_system_score_gemma":0.0007666255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007355711,"about_ca_topic_score_gemma":0.001514125,"domain_scores_codex":[0.9983156,0.0009483837,0.00009553121,0.000162846,0.0001986874,0.0002789166],"domain_scores_gemma":[0.9973478,0.0007878515,0.000804009,0.0002246508,0.0002151856,0.0006205084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8887184,0.008055269,0.04099998,0.0009727686,0.008779582,0.000290824,0.0002540202,0.001320112,0.005530796,0.0001697216,0.001835813,0.04307263],"study_design_scores_gemma":[0.4239228,0.2892031,0.2647121,0.0002860173,0.01252411,0.00061867,0.000269391,0.001460475,0.002737655,0.0006138519,0.003522869,0.0001289531],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887885,0.007843263,0.0003002114,0.0003576913,0.0001121209,0.0002575108,0.001270299,0.00003248257,0.00103784],"genre_scores_gemma":[0.992634,0.002282114,0.0005047813,0.000812671,0.0002505257,0.0003598834,0.002259634,0.0000156407,0.0008807463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005752692,"threshold_uncertainty_score":0.03042352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01631866117627093,"score_gpt":0.2729093367009283,"score_spread":0.2565906755246573,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}